The Role of Inflammation in Age-Related Sarcopenia by Dalle, Sebastiaan et al.
REVIEW
published: 12 December 2017
doi: 10.3389/fphys.2017.01045
Frontiers in Physiology | www.frontiersin.org 1 December 2017 | Volume 8 | Article 1045
Edited by:
Carlos Rosales,
Universidad Nacional Autónoma de
México, Mexico
Reviewed by:
Gautham Yepuri,
University of Fribourg, Switzerland
Rui Curi,
University of São Paulo, Brazil
*Correspondence:
Katrien Koppo
katrien.koppo@kuleuven.be
Specialty section:
This article was submitted to
Integrative Physiology,
a section of the journal
Frontiers in Physiology
Received: 15 September 2017
Accepted: 29 November 2017
Published: 12 December 2017
Citation:
Dalle S, Rossmeislova L and Koppo K
(2017) The Role of Inflammation in
Age-Related Sarcopenia.
Front. Physiol. 8:1045.
doi: 10.3389/fphys.2017.01045
The Role of Inflammation in
Age-Related Sarcopenia
Sebastiaan Dalle 1, Lenka Rossmeislova 2 and Katrien Koppo 1*
1 Exercise Physiology Research Group, Department of Kinesiology, KU Leuven, Leuven, Belgium, 2Department for the Study
of Obesity and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia
Many physiological changes occur with aging. These changes often, directly or indirectly,
result in a deterioration of the quality of life and even in a shortening of life expectancy.
Besides increased levels of reactive oxygen species, DNA damage and cell apoptosis,
another important factor affecting the aging process involves a systemic chronic
low-grade inflammation. This condition has already been shown to be interrelated
with several (sub)clinical conditions, such as insulin resistance, atherosclerosis and
Alzheimer’s disease. Recent evidence, however, shows that chronic low-grade
inflammation also contributes to the loss of muscle mass, strength and functionality,
referred to as sarcopenia, as it affects both muscle protein breakdown and synthesis
through several signaling pathways. Classic interventions to counteract age-related
muscle wasting mainly focus on resistance training and/or protein supplementation
to overcome the anabolic inflexibility from which elderly suffer. Although the elderly
benefit from these classic interventions, the therapeutic potential of anti-inflammatory
strategies is of great interest, as these might add up to/support the anabolic effect
of resistance exercise and/or protein supplementation. In this review, the molecular
interaction between inflammation, anabolic sensitivity and muscle protein metabolism
in sarcopenic elderly will be addressed.
Keywords: muscle wasting, muscle protein metabolism, NSAID, sarcopenia, protein supplementation, resistance
training, inflammation
INTRODUCTION
Aging is generally associated with numerous changes that may, directly or indirectly, affect health
and/or life span. One of the major problems in the aging population is a progressive loss in skeletal
musclemass, muscle strength, and/or functionality, described as age-related sarcopenia. The elderly
suffering from this multifactorial pathological condition are at risk of adverse outcomes such as
physical disability, injuries, frailty, social exclusion, hospitalization and eventually an increased
mortality (Cruz-Jentoft et al., 2010; Visser and Schaap, 2011). Several strategies to attenuate the
loss of muscle mass and other muscle impairments that comes with aging have been developed
(Sakuma and Yamaguchi, 2012; Denison et al., 2015). However, none of these have been proven
successful to fully reverse the muscle wasting condition. Given the high prevalence of sarcopenia
in the aging population and the associated high health care costs, it is of importance to reveal and
elucidate the working mechanisms which underlie muscle protein metabolism in the elderly, in
order to optimize the classic interventions and/or to develop new ones.
Muscle protein metabolism is carefully regulated by counterbalanced fluctuations in muscle
protein breakdown (MPB) and muscle protein synthesis (MPS) (Churchward-Venne et al., 2014).
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In elderly, the balance between MPB and MPS seems to be
disturbed, which progressively increases the loss of skeletal
muscle mass (Churchward-Venne et al., 2014). Many underlying
factors such as hormonal changes, decreased activity, diminished
nutrient intake, and neuronal changes were reported in the
literature (Dirks et al., 2006; Budui et al., 2015), but lately, the role
of inflammation on the regulation of muscle protein metabolism
has gained more and more interest among gerontologists.
Generally, aging is associated with a chronic state of slightly
increased plasma levels of pro-inflammatory mediators, such
as tumor necrosis factor α (TNFα), interleukin 6 (IL-6) and
C-reactive protein (CRP) (for an overview see Table 1). This
state is often referred to as a low-grade inflammation (LGI)
and is, at least partly, the manifestation of increased numbers
of cells leaving the cell cycle and entering the state of
cellular senescence. Indeed, senescent cells acquire a Senescence-
Associated Secretory Phenotype, which induces the production of
pro-inflammatory cytokines (TNFα, IL-6 and an overactivation
of NF-κB) (Tchkonia et al., 2013). Moreover, there is a growing
interest in the association between the telomere/telomerase
system and LGI, as cellular senescence can be triggered by
critically short telomeres, representing irreparable DNA damage
(Kordinas et al., 2016). Also, there are indications that LGI can
directly cause telomere/telomerase dysfunction, enforcing the
vicious LGI circle and stimulating an accelerated aging phenotype
(Jurk et al., 2014).
Although it has been suggested that inflammatory mediators
affect muscle protein metabolism (Frasca and Blomberg, 2016),
it is not fully understood to what extent and through which
signaling pathways they induce muscle wasting. Population-
based data suggest that circulating concentrations of IL-6 and
TNFα are significantly elevated in sarcopenic elderly (Bian et al.,
2017) and it was reported that higher IL-6 and CRP levels
increase the risk of muscle strength loss (Schaap et al., 2006).
In a 10-year longitudinal study in community-dwelling elderly,
plasma concentrations of TNFα, IL-6, and IL-1 were shown
to be strong predictors of morbidity and mortality in older
subjects (Baylis et al., 2013). Furthermore, systemic inflammation
was also reported as one of the primary mediators of skeletal
muscle wasting in diseases such AIDS, COPD, chronic heart
failure and cancer (Sakuma et al., 2015) and it was shown
to accelerate aging in general (Jurk et al., 2014). Without
pronouncing on causality, these findings suggest that there is
a link between inflammatory mediators and muscle mass and
function.
This review is particularly concerned with the recent
progress that has been made in understanding the role
of inflammation in age-related sarcopenia and in muscle
protein metabolism in general. In the first sections, pathways
of both MPB and MPS will be described and related to
inflammation. The following sections will give an overview
of the classic approaches (i.e., aerobic/resistance exercise,
protein supplementation) that attempt to attenuate age-related
sarcopenia. Finally, interventions that target the administration
of compounds with anti-inflammatory properties (vitamin D,
poly-unsaturated fatty acids, non-steroidal anti-inflammatory
drugs) will be discussed as an alternative approach.
MUSCLE PROTEIN BREAKDOWN AND ITS
REGULATION BY INFLAMMATION
As mentioned above, elevated levels of pro-inflammatory
plasma cytokines and acute-phase proteins are often observed
in sarcopenic elderly. Despite strong correlations between
inflammatory markers and the risk for functional decline and
mortality in elderly, conclusive evidence on a causative link
between these markers and age-related sarcopenia is hard to
establish (Reuben et al., 2003; Schaap et al., 2006). Recent
evidence, however, suggests that chronic LGI is, at least partially,
involved in the onset and/or progression of age-related muscle
wasting (Beyer et al., 2012; Argilés et al., 2015). Higher levels
of inflammatory markers were reported to negatively affect
skeletal muscle metabolism through direct catabolic or indirect
mechanisms, such as decreases in growth hormones (Sakuma
et al., 2015). Though, the challenge remains to further uncover
the specific molecular mechanisms through which inflammation
interacts with muscle protein metabolism.
Acute inflammation models are widely applied to study the
molecular mechanisms which link inflammation and muscle
protein metabolism. In rodents, the effect of lipopolysaccharide
injection has been shown to induce muscle catabolism through
inflammatory signaling (Schakman et al., 2012). Accordingly,
blunting an acute infection-induced inflammation improved
muscle performance in elderly (Beyer et al., 2011). However, it
should be noted that acute high-grade inflammation has a limited
translational potential compared to the LGI present in the aged
population.
In general, proteolysis is regulated through four main
pathways (Combaret et al., 2009; Fanzani et al., 2012; Bowen
et al., 2015). The contribution of each pathway is context- (e.g.,
stress vs. basal) or tissue- (e.g., brain vs. muscle) dependent (de
Oliviera Nunes Teixeira et al., 2012). Their mechanisms are also
inter-dependent and might co-regulate proteolysis on a different
hierarchical level (Dirks et al., 2006). In the following section, the
four main proteolytic pathways (ubiquitin proteasome, calpains,
macro autophagy, apoptosis) are briefly discussed, as well as their
interaction(s) with inflammatory signaling.
ATP-Dependent Ubiquitin-Proteasome
Pathway
The ATP-dependent ubiquitin-proteasome pathway is
responsible for degrading the majority of proteins (80–90%)
(Lilienbaum, 2013). The proteolytic core of the 26S complex,
a 20S proteasome, degrades ubiquitin-conjugated proteins
after binding with a regulatory 19S particle. This conjugation
to ubiquitin marks abnormal (misfolded, denaturated) or
short-lived proteins for rapid hydrolysis (Rock et al., 1994).
Ubiquitination of specific substrates is closely regulated by
ubiquitin protein (E3) ligases, such as MuRF1 and MAFbx,
specifically in muscle cells (Bodine and Baehr, 2014). Evidence
indicates that the expression of both E3 ligases is upregulated
in several models of muscle atrophy, such as immobilization,
denervation, hind limb unloading, dexamethasone treatment,
and IL-1-induced cachexia (Bodine and Baehr, 2014). The role of
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TABLE 1 | Studies reporting plasma/serum levels of pro-inflammatory markers
with aging.
Marker Study Main finding
TNFα Bruunsgaard et al., 2000 ↑ plasma [TNFα] in elderly (81 years) vs.
young adults (19–31 years)
Bruunsgaard et al., 1999 ↑ plasma [TNFα] in elderly (>80 years)
(2.5 pg/ml) vs. young adults (18–30 years)
(1.4 pg/ml)
Paolisso et al., 1998 Significant correlation between age and
TNFα (r = 0.64)
Paik et al., 2013 ↑ serum [TNFα] in elderly ♀ (60–79 years)
(>9 pg/ml) vs. younger ♀ (30–59 years)
(±7 pg/ml)
IL-6 Wei et al., 1992 ↑ plasma [IL-6] in elderly (55–75 years) ♂
vs. younger (26–54 years) ♂ and
significant correlation between age and
IL-6 (r = 0.28)
Hager et al., 1994 Significant correlation between age and
IL-6 (r = 0.47)
McKane et al., 1994 Significant correlation between age and
IL-6 in ♀ (r = 0.48)
Checouich et al., 1995 Significant correlation between age and
IL-6 in ♀ (r = 0.75)
Cohen et al., 1997 ↑ mean log(IL-6) and median IL-6 levels in
elderly >90 years vs. elderly 80–89 years
vs. elderly 70–79 years
Harris et al., 1999 ↑ log(IL6) values in elderly >80 years
(0.96±0.65 pg/ml) vs. 71–72 years (0.73
± 0.66 pg/ml)
Ferrucci et al., 2005 ↑ plasma [IL-6] in elderly >75 years (>1.4
pg/ml) vs. young adults (20–39 years)
(0.6 pg/ml)
hs-CRP Ferrucci et al., 2005 ↑ plasma [CRP] in elderly >75 years
(>2.6 mg/l) vs. young adults
(20–39 years) (1.0 mg/l)
Puzianowska-Kuznicka
et al., 2016
↑ plasma [CRP] in elderly >80 years
(>2.4 mg/l) vs. elderly 65–69 years
(2.2 mg/l)
Paik et al., 2013 ↑ serum [CRP] in elderly ♀ (>50 years)
(>1.1 mg/l) vs. younger ♀ (30–59 years)
(±0.95 g/l)
TNFα, tumor necrosis factor α; IL-6, interleukin 6; hs-CRP, high-sensitive C-reactive
protein.
the ubiquitin-proteasome pathway in sarcopenia, however, is less
clear (Bowen et al., 2015; Fan et al., 2016; Wilson et al., 2017).
Some studies reported elevated levels of MAFbx and MuRF1 in
aged rat muscle (Clavel et al., 2006; Altun et al., 2010), while
others observed decreased levels of atrogenes with aging (Erik
et al., 2017). Likewise, in human studies, some authors reported
no differences in skeletal muscle protease activity between
different age groups (Bossola et al., 2008), while others noticed
higher mRNA levels of proteins encoding protease components,
ubiquitin-like proteins and proteins related to ubiquitin function
in elderly compared to younger adults (Welle et al., 2003).
Furthermore, elevated levels of the ubiquitin protein in old
human muscles mainly occurred in fast-twitch muscles, such as
extensor digitorum longus, while no differences were detected in
the slow-twitch soleus muscle (Cai et al., 2004). Dissimilarities
between studies might therefore be attributed to the studied
muscle type, as well as the specific study population, as it was
suggested that age-related muscle wasting is mechanistically
different from muscle wasting-related confounders such as
disuse, bedrest or disease (Erik et al., 2017). A recent review
suggested that elevated levels of pro-inflammatory mediators
(due to LGI), such as TNFα and IL-6, might upregulate this
proteolytic pathway through activation of FOXO3a, which
regulates the ubiquitin-proteasome system (Xia et al., 2017). It
remains to be elucidated, however, whether low levels of these
pro-inflammatory mediators are (on the long-term) sufficient
to induce this proteolytic pathway. To conclude, the ubiquitin-
proteasome pathway is likely to be involved in the regulation
of muscle wasting with aging, partially due to its upregulation
with inactivity. On the other hand, findings on the association
between LGI and the ubiquitin-proteasome pathway are scarce
and need to be further elucidated.
Calpains
Calpains are a family of cysteine proteases with a wide range
of cellular calcium-regulated functions. They are responsible
for the proteolysis of several substrates, including cytoskeletal
and membrane proteins, enzymes and transcription factors
(Dargelos et al., 2008). Furthermore, calpains are also involved
in apoptosis through two major pathways, triggered by
cell death signals (TNF) or endoplasmatic reticulum (ER)
stress, respectively (Dargelos et al., 2008). Reactive oxygen
species (ROS) accumulation with advanced age is able to
upregulate calpain activity directly (Nakashima et al., 2004)
or indirectly by inducing Ca2+ release from the ER or
oxidation of MAPK-dependent pathways (Kefaloyianni et al.,
2006). Although the evidence is scarce, the contribution of
calpains to age-related muscle wasting is not excluded. Higher
calpain availability and activity, and lower availability of its
endogenous inhibitor (calpastatin), were observed in muscles
of old (23 months) compared to young rats (3 months)
and treatment of dystrophic muscle with calpain inhibitors
attenuated muscle degeneration (Dargelos et al., 2007). It was
reported that intracellular [Ca2+] were elevated in aged rodent
muscle cells, potentially contributing to an increased calpain
activation with aging (Andersson et al., 2011). To our knowledge,
there are no data which compare calpain acitivity/availability
in old vs. young human muscles. Calpains can also promote
inflammation through several mechanisms leading to NF-
κB (pro-inflammatory transcription factor) activation and the
production of pro-inflammatory cytokines (Ji et al., 2016).
However, it is unclear whether calpains are involved in muscle
proteolysis through regulation of inflammation in aged muscles.
Therefore, more studies are required to further elaborate the
mechanistic association between calpains and age-related muscle
wasting in humans.
(Macro)Autophagy Pathway
The (macro)autophagy pathway is as a housekeeping mechanism
responsible for the clearance of dysfunctional organelles
and damaged macromolecules (e.g., protein aggregates).
The autophagosome, a double-membrane vesicle, encloses
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macromolecules or organelles for delivery to the lysosome, in
which hydrolases stand in for the degradation into recycled
“building blocks,” e.g., amino acids. The lysosomal protease
cathepsin L was shown to be involved in muscle proteolysis upon
acute infection (Deval et al., 2001). Both in vitro and in vivo
studies reported that elevated levels of the pro-inflammatory
cytokine IL-6 is a first mechanism which links inflammation to
cathepsin-induced muscle atrophy (Ebisui et al., 1995; Tsujinaka
et al., 1995). Whether cathepsin L plays a crucial role in age-
related muscle wasting is less straightforward, as higher levels
of cathepsin L were observed in the soleus muscle of old (30
months) vs. young (3 months) rats (Pattison et al., 2003), while
no different expression patterns were found in the gastrocnemius
muscle of old (30 months) and young (3 months) rats (O’Connell
et al., 2007).
Autophagic activity in the fast-twitch plantaris muscle
decreases with aging, resulting in insufficient clearance and
accumulation of intracellular waste products, such as lipofuscin,
protein aggregates and damaged mitochondria (Wohlgemuth
et al., 2010). In general, autophagy is accepted to be a
promising target to counteract sarcopenia (Fan et al., 2016).
Until now, physical exercise and caloric restriction (CR) were
proven successful in preventing/attenuating the age-related
decrease in autophagic activity. White et al. (2016) reported
that long-term voluntary resistance wheel exercise in elderly
mice increased basal autophagy (increased LC3III/I ratio, marker
of autophagy) compared to sedentary age-matched controls,
while MuRF1 and MAFbx remained unaffected. Another
study found that a mild CR (8%) positively affected muscle
composition, oxidative stress, cell death and autophagy in old
rats, suggesting that mild CRmight be an applicable intervention
to combat age-related sarcopenia, given a sufficiently qualitative
energy intake (Wohlgemuth et al., 2010). In human studies,
markers of autophagy were downregulated in Duchenne
muscular dystrophy patients when compared to healthy controls,
suggesting a decreased autophagic activity in these patients
(Palma et al., 2012). Although evidence is scarce, Jiao and
Demontis (2017) suggested that comparable mechanisms may
apply to the development of age-related muscle wasting in
elderly.
Autophagy is also involved in the regulation of the production
of inflammatory mediators upon acute inflammatory stimuli
(e.g., LPS) (Cadwell, 2016). However, to our knowledge, a
crosstalk between autophagy and LGI was not yet established
in the literature. It is conceivable that inflammation contributes
to a dysregulation of the autophagic/mitophagic activity by
stimulation of oxidative stress (Li et al., 1999; Suematsu et al.,
2003). Nevertheless, it remains to be clarified whether LGI is a
sufficiently strong signal for inducing oxidative stress in muscle
cells. Furthermore, upregulation of the classic NF-κB signaling
is capable of inhibiting autophagy by suppression of autophagy-
related genes (atg5 and beclin 1), but this mechanism was not
confirmed yet in old skeletal muscle cells.
To summarize, skeletal muscle autophagy is downregulated
with advanced aged and indirectly contributes to muscle wasting
due to insufficient clearance of intracellular waste products or
damaged organelles, such as mitochondria. An accumulation
of damaged mitochondria and cellular waste generally induces
oxidative stress, which enforces a pro-inflammatory environment
in favor of catabolic processes.
Apoptosis
Apoptosis is another main player contributing to the onset and
progression of sarcopenia. Apoptosis, the process of programmed
cell death, generally occurs during development and aging
as a homeostatic mechanism to maintain cell populations in
tissues (Elmore, 2007). Dirks and Leeuwenburgh (2002) reported
higher levels of apoptosis (+50%) (measured by nucleosome
fragmentation) in 24 months old rats compared to 6 months
young rats. The same research group also looked at the
mechanisms throughwhich age-related apoptosis affectedmuscle
wasting in skeletal muscles of old rats (Marzetti et al., 2008).
They concluded that muscle weight declined progressively with
advancing age, concomitant with increased apoptotic DNA
fragmentation. A higher susceptibility of aged type II muscle
fibers to TNFα-stimulated apoptotic signaling partially explains
the greater loss of fast twitch muscle fibers with aging (Phillips
and Leeuwenburgh, 2005).
In skeletal muscle, two main routes are described to
induce apoptosis, i.e., an internal and an external pathway.
In the (mitochondrial-dependent) internal pathway, non-
receptor-mediated stimuli in the cytosol, such as elevated
ROS and Ca2+ levels, can directly act upon mitochondrial
homeostasis, increasing their permeability (Nitahara et al., 1998).
Consequently, pro-apoptotic proteins are released from the
intermembrane space into the cytosol. In the external pathway,
ligands (such as TNFα) bind to their respective receptor and
initiate the recruitment of adaptor proteins, eventually resulting
in a death-induced caspase-cascade. As TNFα protein levels are
generally elevated in both circulation and skeletal muscle in
elderly (Greiwe et al., 2001), this pathway might also play a role
in age-related muscle wasting. On the other hand, no apoptosis
of muscle cells was observed in inflammatory myopathies, which
questions the role of this pathway in age-related LGI (Migheli
et al., 1997). Furthermore, it is not fully clear which apoptotic
pathway is the main player in age-related muscle wasting.
Future research should further reveal the contribution of each
apoptotic pathway in order to develop targeted anti-apoptotic
strategies. Similar to autophagy, exercise and mild CR were
found to be effective in attenuating apoptosis with aging (Dirks
and Leeuwenburgh, 2004; Phillips and Leeuwenburgh, 2005;
Wohlgemuth et al., 2010). Despite the extensively studied
association between age-related muscle wasting and apoptosis in
rodents, evidence emerging from human samples are currently
lacking to our knowledge. Therefore, human data studying
the role of apoptosis in sarcopenia are required in order to see
whether the mechanisms/observations are comparable to rodent
models. As concluded by Marzetti and Bernabei (2012), targeting
apoptosis might be an effective intervention to counteract
age-related muscle wasting.
To conclude, several pathways are involved in the regulation
of MPB in sarcopenia. However, it should be noted that possible
other pathways might be active and remain to be confirmed
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in sarcopenic human muscles. These pathways contribute to
muscle wasting to a certain extent, which depends on the
unique context of each muscle fiber, i.e., fiber type, (im)mobility,
oxidative damage, etc. Until now, no studies focused on the
relative contribution of each proteolytic pathway. Therefore,
future research should elucidate the contribution of each
proteolytic pathway, taking into account the specific research
sample/population/condition, in order to allow the development
of effective and specific strategies, which target one or more
proteolytic mechanisms.
MUSCLE PROTEIN SYNTHESIS AND ITS
REGULATION BY INFLAMMATION
Besides its putative role in MPB, inflammation negatively affects
MPS. Already in 1984, Klasing and Austic (1984) established that
high-grade inflammatory challenges, such as E. coli injection,
decreased the in vivo MPS in broilers. Also, a more prolonged
exposure to a high-grade inflammatory milieu, e.g., sepsis,
reduced MPS, through decreased activation of the mTORC1
signaling pathway, and hence muscle mass, as reviewed by
Frost and Lang (2011). The mechanistic link between low-grade
inflammation and the downregulation of aged-related MPS,
however, is less understood.
Muscle protein metabolism is the result of a balance
between an increased post-prandial whole body protein synthesis
and a decreased post-absorptive protein synthesis (Dardevet
et al., 2012). This regulation is mainly orchestrated by the
mTORC1 signaling pathway that integrates environmental
stimuli to control cellular growth (Deldicque et al., 2005). In
the muscle, many mTORC1 stimuli are described, including
amino acids (leucine in particular), insulin, hormones released
during mechanical stimuli as well as contractions per se,
while energy deprivation and stress/hypoxia inhibit mTORC1
activity. Therefore, combined resistance exercise and protein
supplementation has been proven effective in stimulating muscle
growth in adults (Churchward-venne et al., 2012). Under basal
conditions, MPS does not appear to be compromised in elderly,
but its response to physiologic stimuli, such as amino acids,
exercise or insulin (rather as a permissive mediator) is blunted
(Dardevet et al., 2012; Drummond et al., 2012; Haran et al., 2012).
This phenomenon is called “anabolic resistance” and implicates
the need for higher intakes of amino acids and/or higher loads of
resistance exercise, which is difficult to meet in a frail population
that generally suffers from a loss of appetite (Rennie, 2009;
Wysokinski et al., 2015).
Protein Intake As Anabolic Signal
Animal Studies
Inflammation is an important underlying factor that contributes
to the insensitivity to anabolic signals. The research group
of Dardevet confirmed the interference of inflammatory
background (NF-κB, TNFα, IL-6 etc.) with anabolic signaling in
several animal studies. They observed that rats which developed
LGI at 25 months were unresponsive, in their MPS, to food
intake, while in rats without LGI MPS was significantly increased
(Balage et al., 2010). Another study revealed that rats, whose
LGI was attenuated by ibuprofen (NSAID) treatment, exhibited
a restored protein anabolism at post-prandial state (Rieu et al.,
2009). Similarly, the supplementation of an antioxidant mixture
during 7 week, which reduced LGI, was effective in improving
the anabolic response to leucine in skeletal muscles of aged rats
(Marzani et al., 2008). In contrast, Mayot et al. (2008) observed
no differences in MPS between aged-matched 24 months old
LGI and no-LGI rats. However, the authors did not specifically
mention when MPS was measured. Previous studies showed
differences in post-prandial MPS with similar post-absorbative
MPS between LGI and no-LGI aged rats (Rieu et al., 2009; Balage
et al., 2010).
Human Studies
To our knowledge, only two human studies looked at the
association between LGI and meal-induced stimulation of MPS.
A study executed by the research group of Dardevet found
that elderly with LGI (assessed by increased CRP levels) had
no different post-absorptive or post-prandial MPS, compared to
elderly without LGI (Buffière et al., 2015). The authors suggested
that other pro-inflammatory cytokines (TNFα, IL-1/6) might
be more suitable to establish the association between LGI and
anabolic resistance. Furthermore, the post-protein bolus time
interval during which MPS is measured was 5 h in this study,
while other studies recommend a shorter period of 1.5–2 h (Bohé
et al., 2001; Norton et al., 2009; Atherton et al., 2010; Wilson
et al., 2011). Similarly, it was found that ibuprofen (1,800mg.d−1)
administration during 1 week in elderly with LGI did not affect
MPS in response to a whey protein bolus when compared to
placebo (Dideriksen et al., 2016). However, this might be due
to the lack of efficacy of a short NSAID administration period
of 1 week, demonstrated by the lack of decrease in CRP levels
in this group. Furthermore, it is possible that the anabolic effect
of anti-inflammatory strategies (e.g., NSAIDs) might partially
occur via a decreased MPB rather than an increased MPS. Future
human trials are warranted in order to reproduce the findings
of earlier animal studies in which the association between LGI
and anabolic resistance was established (Marzani et al., 2008;
Rieu et al., 2009; Balage et al., 2010). The studies should take
into account the exposure time to LGI, the treatment duration,
applied LGI biomarker(s), sufficiently large sample sizes, and the
post-prandial time interval to assess MPS.
Exercise As Anabolic Signal
Besides the effect of inflammation on the anabolic response
to food/protein intake, its effect on the anabolic response to
exercise is broadly studied. These findings might also contribute
to our understanding of why some elderly gain less muscle mass
with relatively identical exercise stimuli compared to younger
adults. Interesting to note is that NSAID administration in
younger adults vs. elderly results into different adaptations to
exercise training. In younger adults, studies which looked at
the acute effects of NSAID intake on the muscle response to a
single bout of resistance exercise observed a decrease in MPS
compared to placebo (Trappe et al., 2002) and an attenuated
satellite cell proliferation up to 8 days after resistance exercise
(Mikkelsen et al., 2009) or endurance exercise (Mackey et al.,
2007). Also, when long-term (8 week) resistance training was
combined with a daily high-dose (1,200mg.d−1) of ibuprofen
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intake, muscle strength and muscle hypertrophic adaptations
to resistance training were impaired compared to a control
condition (Lilja et al., 2017). In contrast, a moderate dose of
ibuprofen (400mg.d−1) was not sufficient to negatively affect
muscle strength and hypertrophy following 6 week resistance
training (Krentz et al., 2008). Similar to the results observed in
younger adults, a study performed in young rats reported that
ibuprofen administration (∼20mg.kg−1.d−1) during chronic
overload by synergist ablation for 14 days inhibited muscle
hypertrophy with ∼50% (Soltow et al., 2006). The authors,
however, were not sure whether the inhibition of hypertrophy by
the NSAID was caused by its interference with the regeneration
process (decreased satellite cell activity), an attenuation of MPS,
or both. A downregulated MPS response to resistance exercise
with NSAID intake could be ascribed to a blunted prostaglandin
F2α (PGF2α) increase, which normally stimulates skeletal MPS
(Rodemann and Goldberg, 1982).
Contrary to the younger adults, long-term resistance training
combined with NSAID intake, unexpectedly induced additional
gains in muscle mass and/or muscle strength in elderly
(Trappe et al., 2011) and osteoarthritis patients (Petersen et al.,
2011). Trappe et al. (2011) speculated that COX inhibition,
an important mechanism of action of NSAIDs, might have
a relatively stronger inhibitory effect on MPB compared to
MPS in elderly. Besides blunting PGF2α, it was also shown
that COX inhibition might suppress protein degradation by
reducing intramuscular production of prostaglandin E2 (PGE2),
eventually resulting in a higher net protein balance (Rodemann
and Goldberg, 1982). It cannot be excluded that the effect of
NSAID administration on training adaptations is partly related
to its pain-relieving feature, as it was reported that osteoarthritis
patients were able to produce higher maximal strengths after 12
week of ibuprofen (1,200mg.d−1) administration (Petersen et al.,
2011).
In general, it is important to interpret findings concerning the
role of inflammation inmuscle proteinmetabolism upon exercise
with caution, taking into account the study population (adults
vs. elderly with LGI/patient populations), type of exercise/muscle
adaptation (endurance vs. resistance exercise vs. muscle damage
following severe resistance exercise), and the time span of
evaluation of muscle effects (immediately following exercise
vs. long-term effects). Furthermore, studies should focus on
mechanisms through which MPS is affected by LGI. Currently,
many studies do not or only superficially report findings
concerning the COX or prostaglandin pathways.
SATELLITE CELLS AND THEIR
REGULATION BY INFLAMMATION
Satellite cells are adultsmuscle stem cells which play an important
role in muscle growth and repair (Yin et al., 2013). Under
basal conditions, satellite cells remain sublaminal in a quiescent
state. Upon muscle damage, satellite cells exit their quiescent
state, start to proliferate through the sarcolemma and fuse
with existing muscle fibers. These processes are accompanied
by specific expression patterns of myogenic regulator factor
(MRF) genes and protein levels. Adult quiescent satellite cells
express Pax7, while Myf5 and/or MyoD expression is rapidly
upregulated following satellite cell activation, both regulated by
Pax 7 (Cornelison and Wold, 1997; Rudnicki et al., 2008).
The lower regenerative potential of aged muscles can be
explained by a deterioration in satellite cell differentiation and
a reduced Pax7 pool of myogenic stem cells (Collins et al.,
2007; Bernet et al., 2014). Furthermore, recent evidence suggests
that many aged satellite cells switch from the quiescent state
to an irreversible senescence state, and fail to activate and
expand upon injury (Sousa-Victor et al., 2014). The reduced
satellite cell function with aging might be due to altered systemic
factors which affect satellite cell activity and differentiation
(Conboy et al., 2005), such as altered Notch signaling in muscles,
altered circulating levels of protein growth differentiation factor
11, reduced levels of IGF-1, increased inflammation and pro-
inflammatory cytokines (Harridge, 2003; Degens, 2010; Jang
et al., 2011; Sinha et al., 2014). It was shown that TNFα, in
particular, reduces the expression of MyoD and myogenin in
myoblasts and destabilizes MyoD in regenerating mice muscles
(Szalay et al., 1997; Langen et al., 2004). Therefore, it can
be hypothesized that some effects of LGI on muscle protein
metabolism are mediated through changes in satellite cell
function, as TNFα levels affect MRF expression.
CLASSIC APPROACHES TARGETING
AGE-RELATED SARCOPENIA
Many studies currently focus on developing strategies to combat
age-related sarcopenia. In this regard, life style interventions
are of great interest due to their relatively straightforward
applicability. These interventions can be subdivided in two main
categories, i.e., exercise and nutrition. Both aerobic and resistance
exercise, as well as the supplementation of amino acids/proteins,
vitamin D (vit D) and polyunsaturated fatty acids (PUFAs),
have ergogenic implications on the regulation of muscle mass in
elderly. In addition, aerobic exercise, and the supplementation
of vit D or PUFAs showed interesting interactions with the
modulation of inflammation, and might therefore decrease LGI
and subsequently reduce muscle wasting in elderly.
Aerobic Exercise
Aerobic exercise has been suggested as a meaningful strategy
to combat age-related sarcopenia. Besides its effects on
cardiovascular fitness and endurance, aerobic exercise is a potent
inducer of muscle size and strength (Konopka and Harber, 2014).
Recent evidence indicates that endurance exercise-induced
increases in muscle size and strength are due to an increased
MPS, similarly in elderly and young adults (Harber et al., 2012;
Ozaki et al., 2013; Konopka and Harber, 2014). Some studies
concluded that gains in muscle growth, induced by aerobic
exercise, are comparable to the hypertrophic response observed
following resistance training, and that endurance exercise can
be considered an effective countermeasure for muscle loss with
advancing age (Konopka and Harber, 2014).
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The mechanisms, which underlie these positive effects
on the muscle hypertrophic response, are diverse. Firstly,
an upregulation of the transcription of genes involved in
mitochondrial biogenesis, such as CAMK, AMPK, and PGC1α
(Iolascon et al., 2014), increases the muscle mitochondrial
content and function. This eventually results in an attenuated
production of mtROS and thus oxidative stress, regarded
as a potential mediator in skeletal muscle loss with aging
(Jackson, 2016). Secondly, aerobic exercise training also has
an impact on MPB, as basal FOXO3a (upstream of MAFbx
and MuRF1) and myostatin (inhibitor of MPS upstream
of Akt-mTORC1) mRNA levels were reduced in elderly
following a 12 week training program, with concomitant muscle
hypertrophy (Konopka et al., 2010). Another indirect mechanism
involves the partial alleviation of age-related insulin resistance,
which contributes to the age-related anabolic resistance to
protein supplementation (Dickinson et al., 2014; Konopka
and Harber, 2014). Finally, aerobic exercise also exhibits anti-
inflammatory capacities (Montero-Fernandez and Serra-Rexach,
2013). Transient elevations of IL-6, released in response to acute
exercise, might stimulate in the long-term the expression of anti-
inflammatory mediators (such as IL-1 receptor antagonist and
IL-10) and downregulate the expression of pro-inflammatory
mediators (such as TNFα and IL-1β) (Pedersen et al., 2007).
Together, these findings indicate that long-term aerobic training
is effective to overcome anabolic resistance and decrease MPB,
exhibiting a protective effect on muscle wasting.
Resistance Exercise
Despite these promising findings, resistance exercise is generally
accepted as the most effective approach to induce muscle
hypertrophy in both young and old adults, as the relative gain
in muscle size in response to resistance training was found to be
similar in adult (<65 years) and young individuals (Narici et al.,
2004; Slivka et al., 2008; Raue et al., 2009).
The hypertrophic response following resistance training is
mediated through several mechanisms. The mechanical stimuli
per se and growth factors released in response to mechanical
stimuli are both able to independently activate the mTORC1
pathway. The activation of mTORC1 by growth factors (insulin-
like growth factor, mechano growth factor) occurs via the
“classic” PI3K/Akt signaling (Bodine et al., 2001). Mechanical
stimuli have a more acute effect, which is, contrarily, not always
dependent on PI3K/Akt signaling (Hornberger et al., 2004). It
was suggested that mechanical signals can activate the mTORC1
pathway after they are converted in biological responses. The
proposed mediators of these stimuli are phosphatidic acid,
which is highly produced in response to stretching and activates
p70S6K, and integrins, which connect the extracellular matrix to
the muscle cell membrane (Zanchi and Lancha, 2008).
Despite positive findings in adults (<65 years), Peterson et al.
(2011) reported less pronounced gains in lean body mass in
response to resistance exercise in elderly. This indicates that
the myocellular response to resistance training is blunted in
advanced age (Narici et al., 2004; Slivka et al., 2008; Raue et al.,
2009). The precise mechanism(s), underlying the development
of this anabolic insensitivity in elderly, are not fully understood
yet. It is likely, however, that the limited activation of the
mTORC1 axis following an acute bout of exercise in elderly
is an important contributor to this observation (Kumar et al.,
2009; Fry et al., 2011). Accordingly, one study found an impaired
downregulation of REDD1 (potent inhibitor of mTORC1)
mRNA in elderly following resistance exercise (Greig et al., 2011).
Nevertheless, it is conceivable that also inflammation is somehow
involved in the blunted adaptation to resistance exercise, since
the effect of resistance training on gains in muscle mass and
muscle strength was reinforced when combined with NSAID
administration in elderly (Trappe et al., 2011).
Protein Supplementation
Among the nutritional interventions, supplementation with
proteins/amino acids (leucine in particular) is widely applied
to treat muscle loss in elderly. Proteins stimulate MPS, and
are therefore generally expected to attenuate muscle wasting.
The effects of protein supplementation on MPS are mediated
through several mechanisms. Firstly, protein synthesis is induced
by cell swelling per se (Lang et al., 1993). This swelling can
be obtained through an increased cellular osmolarity, due to
Na+-dependent transport into the cell or accumulation of
metabolites, such as glutamate. Secondly, mTORC1 regulates
protein translation by controlling the phosphorylation of its
downstream targets p70S6K and 4E-BP1 (Laplante and Sabatini,
2012). Protein supplementation induces the mTORC1 activation
via two independent ways. Amino acids can be directly sensed by
GTPases, amino acid transporters and receptors, which transmit
the signal to mTORC1 by different signaling pathways (Zheng
et al., 2016). This cascade occurs without modulation of PI3K and
its downstream effector Akt. Additionally, branched chain amino
acids induce the release of insulin, which act upon the PI3K-
Akt-mTORC1 axis. Due to its vasodilatory effect, insulin also
facilitates the uptake of amino acids from the blood circulation
by the skeletal muscle cells. It is accepted that the availability
of insulin plays a rather permissive effect, as it was shown
that only ∼10% of the post-prandial protein anabolism was
dependent on insulin signaling, while ∼90% was related to the
increased amino acid levels (Volpi et al., 1996). Furthermore,
Abdulla et al. (2016) reported that, in healthy adults, the positive
effects of insulin per se on MPS became significant, only when
the amino acid delivery to the skeletal muscle increased. At
fixed amino acids concentrations, supraphysiological levels of
insulin did not induce further increments in MPS (Greenhaff
et al., 2008). To summarize, the beneficial effect of physiological
hyperinsulinemia per se on MPS can only be observed as long as
it concomitantly increases amino acid delivery and availability to
the muscle (Fujita et al., 2006).
Among the amino acids, the essential amino acids (EAAs)
(e.g., leucine) are the most effective to stimulate MPS (Stipanuk,
2007). Along with its stimulatory effect, leucine in particular
also decreases MPB (Buse and Reid, 1975). Another mechanism
ascribed to leucine involves its capacity to reverse insulin
insensitivity in elderly. The precise mechanism(s) of the
insulin sensitizing effects of long-term leucine supplementation
are not fully elucidated yet, but may act through leucine-
induced decreased adiposity, hepatic glucose production, hepatic
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steatosis, and adipose tissue inflammation (Zhang et al., 2007;
Macotela et al., 2011; Binder et al., 2013). Insulin resistance,
which often occurs with aging, is an important contributor to
the pathophysiology of age-related sarcopenia, as this negatively
affects mTORC1 signaling (Cleasby et al., 2016). Therefore,
interventions that might positively affect the insulin sensitivity,
are very likely to increase MPS (Børsheim et al., 2006; Solerte
et al., 2008). Recently, a downstream metabolite of leucine, β-
hydroxy β-methylbutyrate (HMB), gained much interest due to
its broad ergogenic effects on muscle protein metabolism. HMB
was shown to stimulate mTORC1 and the proliferation and
differentiation of satellite cells (Cruz-Jentoft, 2017). Besides its
anabolic actions, HMB was shown to exert anti-catabolic actions
through the attenuation of proteasomal-mediated proteolysis
and mitochondrial-mediated myonuclear apoptosis (Smith et al.,
2005; Kovarik et al., 2010; Hao et al., 2011;Wilkinson et al., 2013).
Similar to resistance exercise, many elderly suffer from a
blunted anabolic response to EAA intake. Therefore, it is
generally suggested that larger doses may, at least partially,
compensate for the blunted anabolic sensitivity (Paddon-Jones
et al., 2004; Cuthbertson et al., 2005; Katsanos et al., 2006;
Moore et al., 2015). Recent evidence-based recommendations
state that 1.2–1.5 g.kg−1 BW should be ingested on a daily base
by elderly, while the RDA for young adults is 0.8 g.kg−1 BW
(Deer and Volpi, 2015; Devries and Phillips, 2015; Nowson and
O’Connell, 2015; Moore et al., 2017). Furthermore, an intake of
25–30 g high quality proteins (∼10 g EAAs) each meal has been
proven to maximally stimulate MPS in elderly for 24 h (Deer and
Volpi, 2015; Devries and Phillips, 2015; Nowson and O’Connell,
2015).
Despite the well-established positive findings of acute
protein/leucine supplementation on the stimulation of MPS,
the effectiveness of long-term protein supplementation as a
treatment for age-related sarcopenia is more equivocal. On the
one hand, a recent meta-analysis demonstrated the beneficial
effects of leucine supplementation on MPS in elderly (be it
without changes in lean body mass or lean leg mass) (Xu et al.,
2015), while other studies failed to show a consistent effect
of protein/leucine supplementation on muscle mass, strength
and/or function (Bonnefoy et al., 2003; Verhoeven et al.,
2009; Tieland et al., 2012b). The review of Hickson (2015)
concluded that both whole-protein and EAA supplementation
failed to show consistent effects on muscle mass, strength or
function. Accordingly, it was suggested that, despite its acute
anabolic effects, leucine supplementation has no beneficial effects
on skeletal muscle mass or function on the long-term in
muscle wasting conditions (Ham et al., 2014). In contrast to
leucine, studies that focused on HMB yielded more consistent
results (Hickson, 2015; Wu et al., 2015). Consequently, HMB
might be more effective for the preservation of muscle mass,
strength and functionality in elderly. However, more research
is required to further elucidate the efficacy of the long-term
intake of amino acids and their metabolites to combat age-related
sarcopenia. In addition, it might be of great interest to develop
alternative treatments that sensitize the skeletal muscle to leucine
and anabolic stimuli in general, such as anti-inflammatory
strategies.
Combined Protein Supplementation and
Resistance Exercise
Since both protein supplementation and resistance exercise are
suggested to induce muscle hypertrophy by stimulating the
mTORC1 signaling pathway, it is not surprising that their
combined effect was broadly researched. In healthy adults,
evidence indicates that the combined intervention induces
additional gains in muscle mass and muscle strength, when
compared to resistance training as such (Morton et al., 2017).
In elderly, however, the findings are less conclusive, as many
studies reported no superiority of resistance exercise with
protein supplementation compared to resistance exercise as such
(Fiatarone et al., 1994; Godard et al., 2002; Candow et al.,
2006; Kukuljan et al., 2009; Verdijk et al., 2009; Denison et al.,
2015; Thomas et al., 2016). Denison et al. (2015) suggested
that an additional effect due to protein supplementation was
mainly to be expected in subjects with low basal protein
intakes, whereas those with adequate basal intakes would benefit
less from additional protein supplementation. Since adequate
protein intake is often problematic in frail and institutionalized
elderly, it is of importance to not only emphasize on protein
supplementation during resistance training, but also to ensure a
sufficient basal protein intake in these subpopulations (Tieland
et al., 2012a; Thomas et al., 2016).
INFLAMMATION-REDUCING
APPROACHES TARGETING AGE-RELATED
SARCOPENIA
As stated earlier, inflammation is closely involved in both the
blunted anabolic response and increased catabolic processes
in elderly. In the following section, nutritional strategies that
attenuate muscle wasting in elderly, partially regulated through
anti-inflammatory mechanisms, will be discussed. Figure 1 gives
an overview of the mechanisms through which LGI may
indirectly affect age-related muscle wasting.
Vitamin D Supplementation
Historically, vit D supplementation has been broadly applied
in elderly, due to its well established effects on calcium (Ca2+)
and bone homeostasis. It was shown that supplementation of
vit D, preferably together with Ca2+, increases bone mineral
density and decreases the risk of osteoporotic fractures in elderly.
More recently, vit D has also been shown to play a regulatory
role in metabolic pathways implicated in muscle wasting, and
in the regulation of the immune system. It seems that vit D has
beneficial effects on muscle strength (Muir and Montero-odasso,
2011; Beaudart et al., 2014), however, this only seems to apply
to vit D-deficient elderly (Janssen et al., 2002; Stockton et al.,
2011). In contrast, muscle mass seems not to be increased by vit
D supplementation in elderly (Beaudart et al., 2014). Since the
prevalence of vit D deficiency is very high among elderly (up to
42% in the U.S.), its supplementation should be recognized as
an important intervention in elderly (Forrest and Stuhldreher,
2011).
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FIGURE 1 | Schematic illustration of the mechanisms through which LGI may indirectly affect age-related muscle wasting. LGI, low-grade inflammation; AA, amino
acid; AT, adipose tissue; MPS, muscle protein synthesis, MPB, muscle protein breakdown. Red lines contribute to the induction of muscle wasting; green lines to the
attenuation of muscle wasting. Dashed lines: inhibitory signaling; full lines: stimulatory signaling. Additional to the association between LGI and age-related muscle
wasting, the beneficial effects of classic strategies such as exercise and protein supplementation are illustrated.
The mechanisms through which vit D affects muscle cell
functioning can be broadly divided into two categories, the
genomic and non-genomic effects. For the genomic effects,
binding of vit D to its nuclear receptor, a transcription factor,
is required. This will result in changes in gene transcription,
e.g., stimulation of cell proliferation and terminal differentiation,
among others, both important in muscle development and
growth (Boland, 1986; Ceglia and Harris, 2013). Indeed,
decreases in muscle functioning related to vit D signaling with
aging, can be mainly ascribed to the decreased vit D receptor
expression in old skeletal muscle cells (Bischoff-Ferrari et al.,
2004). Salles et al. (2013) also showed that vit D positively
affected the expression of proteins involved in the insulin-Akt-
mTORC1 pathway, along with an increased MPS in C2C12
muscle cells. These findings were recently confirmed in vivo, as
vit D supplementation restored the blunted anabolic response in
vit D-deficient old rats (Chanet et al., 2017). To our knowledge,
these mechanisms were not yet studied in humans. The non-
genomic “rapid” effects are mediated through the membrane-
bound vit D receptor. Firstly, this regulates the influx of Ca2+
and inorganic phosphate in skeletal muscle cells, important for
the regulation of muscle contractions and for the production
of energy-rich phosphate groups, respectively. A second non-
genomic effect involves the activation of protein kinase C.
This kinase plays a crucial role in the regulation of MPS by
mediating the anabolic signaling of both insulin (in an IRS1-
and PI3K-dependent way) and leucine on protein synthesis
(Selless and Boland, 1991; Mendez et al., 1997; Yagasaki et al.,
2003).
Asmentioned earlier, vit D alsomodulates the immune system
and might therefore be an interesting target to combat LGI.
Apart from muscle cells, the vit D receptor is expressed by cells
which play a key role in immunity, such as macrophages and
lymphocytes. Binding of vit D to its receptor in macrophages
inhibits NF-κB activity (a transcriptional key regulator in
the upregulation of pro-inflammatory mediators), and thereby
attenuates TNFα production (Cohen-lahav et al., 2006). The
same NF-κB-dependent inhibition of cytokine secretion through
vit D signaling is present in lymphocytes (Calton et al., 2015). In
murine models, vit D signaling also stimulates the production of
lymphoid cell lineages with anti-inflammatory properties, such
as Treg cells (Tian et al., 2015). Another mechanism involves a
direct induction of relevant genes by vit D in specific liver cells,
resulting in an elevated production of insulin-like growth factor-
1 (IGF-1), which has previously been shown to engage in anti-
inflammatory actions (Bellini et al., 2011; Yu et al., 2012; Wang
et al., 2017). Furthermore, IGF-1 is also engaged as a stimulator
of cell growth and proliferation through activation of the Akt
signaling pathway.
Compared to rodent studies, findings from human
interventions with vit D supplementation are very hard to
interpret. Most human studies, which link vit D signaling to
anti-inflammatory actions, focused on several diseases, each
with their specific inflammatory context, which results in
ambiguous evidence. Consequently, there is a need for human
trials, which study the effects of vit D supplementation in elderly
with limited comorbidities. In general, it can be concluded
that vit D supplementation might be useful in elderly, as they
belong to a population that is prone to vit D deficiency due to
reduced exposure to sunlight, low oral intake of vit D, intestinal
malabsorption, and decreased vit D hydroxylase activity in the
kidneys.
N-3 Polyunsaturated Fatty Acids
N-3 poly unsaturated fatty acids (PUFAs) are characterized
by a double bond at the third carbon from the methyl
Frontiers in Physiology | www.frontiersin.org 9 December 2017 | Volume 8 | Article 1045
Dalle et al. Inflammation and Age-Related Sarcopenia
end of the carbon chain. Besides their role as a structural
component, i.e., in membranes, PUFAs function in several
cellular processes as regulatory or signaling molecules. In elderly,
long-term n-3 PUFA supplementation increases muscle volume
and muscle strength (Smith et al., 2015). Furthermore, n-3
PUFA/fish oil supplementation has additional beneficial effects
on resistance training-induced muscle functionality in elderly
women (Rodacki et al., 2012; Da Boit et al., 2017), though without
changes in muscle mass (Da Boit et al., 2017). The anabolic
effects of n-3 PUFAs can be ascribed to an increased MPS,
mainly regulated through activation of the mTORC1 signaling
pathway, as observed in both animal (Gingras et al., 2007; Wei
et al., 2013) and human (Smith et al., 2011; Yoshino et al.,
2016) studies. A possible link can be found with an increased
insulin sensitivity, as it was shown that PUFA supplementation
leads to increased phosphorylation of the insulin receptor
and its downstream signaling (Kamolrat and Gray, 2013; Wei
et al., 2013). Furthermore, enhanced insulin signaling induces
vasodilation, which increases amino acid availability (Smith,
2016).
Besides their anabolic capacities, n-3 PUFAs possess well-
established anti-inflammatory properties. Once transported into
the cell, PUFAs are either stored, oxidized or incorporated into
cellular membranes. PUFAs, released from the cell membranes,
may form prostanoids, which are involved in direct inflammatory
actions or regulate the production of other mediators such
as inflammatory cytokines (Williams et al., 2000). When
consuming a typical western diet, rather high rates of the n-6
PUFA arachidonic acid (ARA) are integrated in the membrane
phospholipids of inflammatory cells, while proportions of the n-
3 PUFA eicosapentaenoic acid (EPA) or docosahexaenoic acid
(DHA) are low. Therefore, ARA is often the main substrate for
the formation of prostanoid synthesis (Bagga et al., 2003). After
mobilization from the membrane phospholipids by the enzyme
phospholipase A2, ARA binds the cyclooxygenase enzymes
(COX-1/2) from which downstream intermediates are further
metabolized to finally synthesize pro-inflammatory prostanoids.
When more n-3 PUFAs are integrated in the diet, less n-6 PUFA-
derived pro-inflammatory prostanoids will be formed.
Early findings indicate the association betweenmuscle protein
metabolism and a certain subclass of the prostanoids, i.e.,
prostaglandins (Rodemann and Goldberg, 1982; Rodemann
et al., 1982). The research group of Goldberg observed that
PGE2, produced by muscle upon ARA incubation, consistently
stimulated protein degradation (+22%), while no significant
changes in MPS were observed. PGF2α, derived from ARA,
contrarily, had no effect on MPB but increased MPS. These
findings are of great interest from an aging perspective, as
an increased LGI was related to an overexpression of COX-
2, among others, eventually evoking a pro-inflammatory status
(e.g., elevated levels of PGE2) (Chung et al., 2006). More recently,
Standley et al. (2013) suggested that COX-induced expression of
PGE2 increased the expression of IL-6 and MuRF-1, which are
both related to MPB and might therefore explain the mechanism
through which PGE2 is linked to muscle proteolysis.
Despite promising associations between n-3 PUFAs and
muscle metabolism, this area of research needs to be further
explored. Animal studies revealed that the EPA was effective
in attenuating the ubiquitin-proteasome pathway in several
muscle wasting conditions, such as fasting, cachexia and
arthritis (Whitehouse and Tisdale, 2001; Whitehouse et al.,
2001; Castillero et al., 2009). Furthermore, in obese adults,
with elevated inflammatory mediators (e.g., IL-6), n-3 PUFAs
were effective in alleviating systemic inflammation (Itariu
et al., 2012; Allaire et al., 2016). It would be of interest
to expand this knowledge to elderly suffering from LGI in
order to develop strategies that support/optimize the current
interventions. Recently, a paper confirmed that n-3 PUFA
supplementation in elderly downregulated pathways related to
calpain- and ubiquitin-mediated proteolysis in skeletal muscle
(Yoshino et al., 2016). This shows the anti-proteolytic potential
of n-3 PUFAs in age-related muscle wasting.
The COX-Pathway and Muscle Metabolism
There seems to be an interesting link between inflammation and
muscle protein metabolism. A lower MPS was reported in old
rats suffering from LGI (Balage et al., 2010) and their MPS was
increased when the LGI was blunted by NSAID administration
(Marzani et al., 2008; Rieu et al., 2009). Interestingly, LGI also
impaired muscle protein anabolism in response to resistance
training in elderly (Trappe et al., 2002). As mentioned before,
these effects might be related to certain intermediates of the
COX pathway, i.e., prostaglandins. COX-inhibiting interventions
through NSAID administration might therefore be effective
in improving muscle protein metabolism and thus for the
treatment of muscle wasting (Greig et al., 2009). This idea
was further strengthened by the cross-sectional study of Landi
et al. (2013), which investigated the relationship between NSAID
use and sarcopenia in community-dwelling elderly (>80 years).
In this study only 9% of the subjects that chronically used
NSAIDs were affected by sarcopenia, compared to 32% in the
non-user group (Landi et al., 2013). Although it tantalizing
to promote daily consumption of NSAIDs to overcome the
age-related muscle anabolic resistance, the associated risks,
such as gastric, cardiovascular and hepato-renal adverse events,
cannot be denied (Greig et al., 2009). In this perspective,
other anti-inflammatory compounds might be of great interest
in the search for a physiological-holistic approach to combat
age-related sarcopenia. It should be noted though that anti-
inflammatory compounds, inhibiting COX-2 and concomitant
PG synthesis, might negatively affect skeletal muscle regeneration
and hypertrophy. Some studies reported that COX-2 inhibition
resulted in a decreased size of regenerating muscle fibers
following injury and negatively affected ex vivo satellite cell
proliferation, differentiation and fusion (Bondesen et al., 2004;
Mendias et al., 2004). Furthermore, COX-2 inhibition decreased
intramuscular macrophage accumulation and cell proliferation,
and the consequent hypertrophic response in a synergist ablation
model (Novak et al., 2009). Future studies should clarify
whether these inhibitory effects on muscle regeneration also
apply to sarcopenic elderly, and/or whether nutritional anti-
inflammatory strategies can enforce the positive effects of classic
strategies.
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CONCLUSION
Plural mechanisms were shown to contribute to the etiology
and/or progression of muscle wasting with advancing
age. Somehow, many of these mechanisms interfere with
inflammatory mediators. However, further research is required
to determine through which mechanisms inflammation
directly or indirectly affects MPB and MPS with aging. Classic
interventions such as protein supplementation and resistance
exercise are generally accepted to be the most appropriate
to positively affect muscle protein metabolism in elderly.
However, not all studies univocally support the effectiveness
of these strategies for long-term treatment of age-related
muscle wasting. Elderly, and very old/frail seniors in particular,
might benefit from a strategy which primarily focusses on
alleviating their muscle insensitivity to anabolic stimuli. In
this regard, the treatment of LGI in these elderly might play
an important role. Given the limited applicability of NSAIDs,
other (non-pharmaceutical) approaches to attenuate LGI should
gain more attention. Additionally, future research should also
focus on possible interactions with the “classical” anabolic
treatments, in order to develop a holistic approach, that takes
into account the personal capabilities and experiences of the old
individual.
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